Seroprevalence of SARS-CoV-2 in Pakistan: An update on epidemiological trends

Muhammad Waqar; Braira Wahid; Muhammad Idrees; Muhammad Ali; Zobaria Rehman

doi:10.1515/znc-2020-0291

Seroprevalence of SARS-CoV-2 in Pakistan: An update on epidemiological trends

Muhammad Waqar, Braira Wahid, Muhammad Idrees, Muhammad Ali, Zobaria Rehman

Research output: Contribution to journal › Article › peer-review

Abstract

The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals processed at Genome Center for Molecular Based Diagnostics and Research Pakistan, 313 (49.3%) were found SARS-CoV-2 seropositive. The study also confirmed more seroprevalence in elderly patients (>80 years) and children less than 13 years.

Original language	English
Pages (from-to)	425-429
Number of pages	5
Journal	Zeitschrift fur Naturforschung - Section C Journal of Biosciences
Volume	76
Issue number	9-10
DOIs	https://doi.org/10.1515/znc-2020-0291
Publication status	Published - Sept 2021
Externally published	Yes

Keywords

COVID19
epidemiology
Pakistan
SARS-CoV-2
seroprevalence

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1515/znc-2020-0291Licence: In Copyright

Cite this

@article{d0c630a73df4425f91a76731941bfc3b,

title = "Seroprevalence of SARS-CoV-2 in Pakistan: An update on epidemiological trends",

abstract = "The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals processed at Genome Center for Molecular Based Diagnostics and Research Pakistan, 313 (49.3%) were found SARS-CoV-2 seropositive. The study also confirmed more seroprevalence in elderly patients (>80 years) and children less than 13 years.",

keywords = "COVID19, epidemiology, Pakistan, SARS-CoV-2, seroprevalence",

author = "Muhammad Waqar and Braira Wahid and Muhammad Idrees and Muhammad Ali and Zobaria Rehman",

year = "2021",

month = sep,

doi = "10.1515/znc-2020-0291",

language = "English",

volume = "76",

pages = "425--429",

journal = "Zeitschrift fur Naturforschung - Section C Journal of Biosciences",

issn = "0939-5075",

publisher = "Walter de Gruyter GmbH",

number = "9-10",

}

TY - JOUR

T1 - Seroprevalence of SARS-CoV-2 in Pakistan

T2 - An update on epidemiological trends

AU - Waqar, Muhammad

AU - Wahid, Braira

AU - Idrees, Muhammad

AU - Ali, Muhammad

AU - Rehman, Zobaria

PY - 2021/9

Y1 - 2021/9

N2 - The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals processed at Genome Center for Molecular Based Diagnostics and Research Pakistan, 313 (49.3%) were found SARS-CoV-2 seropositive. The study also confirmed more seroprevalence in elderly patients (>80 years) and children less than 13 years.

AB - The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals processed at Genome Center for Molecular Based Diagnostics and Research Pakistan, 313 (49.3%) were found SARS-CoV-2 seropositive. The study also confirmed more seroprevalence in elderly patients (>80 years) and children less than 13 years.

KW - COVID19

KW - epidemiology

KW - Pakistan

KW - SARS-CoV-2

KW - seroprevalence

UR - http://www.scopus.com/inward/record.url?scp=85109098193&partnerID=8YFLogxK

U2 - 10.1515/znc-2020-0291

DO - 10.1515/znc-2020-0291

M3 - Article

C2 - 34161693

AN - SCOPUS:85109098193

SN - 0939-5075

VL - 76

SP - 425

EP - 429

JO - Zeitschrift fur Naturforschung - Section C Journal of Biosciences

JF - Zeitschrift fur Naturforschung - Section C Journal of Biosciences

IS - 9-10

ER -

Seroprevalence of SARS-CoV-2 in Pakistan: An update on epidemiological trends

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this